Active inhibition of plasma cell development in resting B cells by microphthalmia-associated transcription factor.

J Exp Med

Department of Internal Medicine/Rheumatology, Washington University School of Medicine, Campus Box 8045, CSRB 6617, 660 S. Euclid Ave., St. Louis, MO 63110, USA.

Published: July 2004

B cell terminal differentiation involves development into an antibody-secreting plasma cell, reflecting the concerted activation of proplasma cell transcriptional regulators, such as Blimp-1, IRF-4, and Xbp-1. Here, we show that the microphthalmia-associated transcription factor (Mitf) is highly expressed in naive B cells, where it antagonizes the process of terminal differentiation through the repression of IRF-4. Defective Mitf activity results in spontaneous B cell activation, antibody secretion, and autoantibody production. Conversely, ectopic Mitf expression suppresses the expression of IRF-4, the plasma cell marker CD138, and antibody secretion. Thus, Mitf regulates B cell homeostasis by suppressing the antibody-secreting fate.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213314PMC
http://dx.doi.org/10.1084/jem.20040612DOI Listing

Publication Analysis

Top Keywords

plasma cell
12
microphthalmia-associated transcription
8
transcription factor
8
terminal differentiation
8
antibody secretion
8
cell
7
active inhibition
4
inhibition plasma
4
cell development
4
development resting
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!